Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
Background: The multidrug-resistant Gram-negative bacteria (MDRGNBs) have emerged as important pathogens recently. Cefoperazone-sulbactam is active against a great proportion of those MDRGNBs. However, the susceptibilities data of cefoperazone-sulbactam are lacking in Taiwan. Object: This study was...
Main Authors: | Tsung-Ta Chiang, Hung-Jen Tang, Cheng-Hsun Chiu, Te-Li Chen, Mao-Wang Ho, Chen-Hsiang Lee, Wang-Huei Sheng, Ya-Sung Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Medical Sciences |
Subjects: | |
Online Access: | http://jms.ndmctsgh.edu.tw/article.asp?issn=1011-4564;year=2016;volume=36;issue=6;spage=229;epage=233;aulast=Chiang |
Similar Items
-
Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
by: Ergenekon Karagoz, et al.
Published: (2015-12-01) -
In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
by: Ming-Jen Sheu, et al.
Published: (2020-02-01) -
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Lai CC, et al.
Published: (2018-12-01) -
Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
by: Ling Zhou, et al.
Published: (2019-11-01) -
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01)